Skip to main content
Onward Medical N.V. logo

Onward Medical N.V. — Investor Relations & Filings

Ticker · ONWD ISIN · NL0015000HT4 LEI · 9845007A2CC4C8BFSB80 AS Manufacturing
Open in API
Filings indexed 116 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country NL Netherlands
Listing AS ONWD

About Onward Medical N.V.

https://www.onwd.com/

Onward Medical is a neurotechnology company that develops therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's commercial product, the ARC-EX System, is an external, non-invasive spinal cord stimulation therapy indicated to improve hand sensation and strength for individuals with chronic cervical SCI. The system is used in rehabilitation clinics and is also cleared for home use. Onward Medical is also advancing its investigational implantable platform, the ARC-IM System, which is designed to address other functional deficits, including blood pressure regulation, following spinal cord injury.

Recent filings

Filing Released Lang Actions
ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
Regulatory Filings
2026-05-13 English
ONWARD Medical Publishes Closing of Bookbuild Offering
Capital/Financing Update Classification · 86% confidence The document is a press release announcing the closing of a private placement (bookbuild offering) raising EUR 40.6M and admission of new shares to trading. This is clearly a financing update regarding fundraising and capital structure changes, fitting the Capital/Financing Update category.
2026-04-21 English
ONWARD Medical Publishes Closing of Bookbuild Offering
Capital/Financing Update Classification · 88% confidence The document is a press release announcing the closing of a bookbuild private placement, the gross proceeds raised, issuance of new shares, and admission to trading on exchanges. This is clearly a financing activity update rather than an earnings release, AGM material, or regulatory filing. Therefore it fits the Capital/Financing Update category.
2026-04-20 English
ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
Share Issue/Capital Change Classification · 93% confidence The document is a corporate press release announcing a EUR 40.6 million private placement of 13,520,254 new ordinary shares, detailing issue price, investors, listing dates, lock-up, and use of proceeds. This is not a financial report or earnings release but a financing announcement involving issuance of new shares. It fits the "Share Issue/Capital Change" category.
2026-04-17 English
ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
Share Issue/Capital Change Classification · 85% confidence The document is a press release announcing a successful capital raise of EUR 40.6 million via a private placement of 13.5 million new ordinary shares at EUR 3.00 each. It details the new share issuance, use of proceeds, listing dates, and lock-up arrangements. This is not an earnings release or management discussion but rather an announcement of a share issue/capital change. Therefore it falls under the “Share Issue/Capital Change” category (SHA).
2026-04-16 English
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million
Capital/Financing Update Classification · 91% confidence The document is a press release announcing a capital increase by way of a private placement, describing the fundraising terms, bookbuilding, issue of new shares, and use of proceeds. It clearly details a financing activity (fundraising/issuance of shares) rather than reporting on quarterly results, AGM materials, or board changes. This fits the Capital/Financing Update category (CAP).
2026-04-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.